Clinical Trial Update: A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus in Pregnant Women and in Infants Born to Vaccinated Mothers [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Moderna's mRNA-1345 RSV vaccine given to pregnant women and infants of vaccinated mothers; the study is active but not recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Drugs mentioned

• mRNA-1345

Snippet

Sponsor: ModernaTX, Inc. | Conditions: Respiratory Syncytial Virus | Phase 2 | Status: ACTIVE_NOT_RECRUITING